Okimoto, T., Mizukami, K., Ogawa, R., Okamoto, K., Shuto, M., Fukuda, K., . . . Murakami, K. (2016). Esomeprazole- or rabeprazole-based triple therapy eradicated Helicobacter pylori comparably regardless of clarithromycin susceptibility and CYP2C19 genotypes. J Clin Biochem Nutr.
Citação norma ChicagoOkimoto, Tadayoshi, Kazuhiro Mizukami, Ryo Ogawa, Kazuhisa Okamoto, Mitsutaka Shuto, Kensuke Fukuda, Masaaki Kodama, and Kazunari Murakami. "Esomeprazole- or Rabeprazole-based Triple Therapy Eradicated Helicobacter Pylori Comparably Regardless of Clarithromycin Susceptibility and CYP2C19 Genotypes." J Clin Biochem Nutr 2016.
Citação norma MLAOkimoto, Tadayoshi, et al. "Esomeprazole- or Rabeprazole-based Triple Therapy Eradicated Helicobacter Pylori Comparably Regardless of Clarithromycin Susceptibility and CYP2C19 Genotypes." J Clin Biochem Nutr 2016.